Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Probl Cardiol ; 49(1 Pt C): 102116, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37802168

ABSTRACT

Mpox, a novel epidemic disease, has broken out the period of coronavirus disease 2019 since May 2022, which was caused by the mpox virus. Up to 12 September 2023, there are more than 90,439 confirmed mpox cases in over 115 countries all over the world. Moreover, the outbreak of mpox in 2022 was verified to be Clade II rather than Clade I. Highlighting the significance of this finding, a growing body of literature suggests that mpox may lead to a series of cardiovascular complications, including myocarditis and pericarditis. It is indeed crucial to acquire more knowledge about mpox from a perspective from the clinical cardiologist. In this review, we would discuss the epidemiological characteristics and primary treatments of mpox to attempt to provide a framework for cardiovascular physicians.


Subject(s)
COVID-19 , Cardiovascular Diseases , Mpox (monkeypox) , Myocarditis , Pericarditis , Humans , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , COVID-19/epidemiology , Pericarditis/epidemiology , Pericarditis/etiology , Pericarditis/therapy
2.
Curr Probl Cardiol ; 49(1 Pt B): 102088, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37716542

ABSTRACT

Vascular disease is a common problem with high mortality all over the world. Apelin-13, a key subtype of apelin, takes part in many physiological and pathological responses via regulating many target genes and target molecules or participating in many signaling pathways. More and more studies have demonstrated that apelin-13 is implicated in the onset and progression of vascular disease in recent years. It has been shown that apelin-13 could ameliorate vascular disease by inhibiting inflammation, restraining apoptosis, suppressing oxidative stress, and facilitating autophagy. In this article, we sum up the progress of apelin-13 in the occurrence and development of vascular disease and offer some insightful views about the treatment and prevention strategies of vascular disease.


Subject(s)
Intercellular Signaling Peptides and Proteins , Vascular Diseases , Humans , Intercellular Signaling Peptides and Proteins/therapeutic use , Vascular Diseases/prevention & control
3.
Curr Probl Cardiol ; 49(1 Pt B): 102096, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37741601

ABSTRACT

Nuclear factor interleukin-3 (NFIL3), a proline- and acidic-residue-rich (PAR) bZIP transcription factor, is called the E4 binding protein 4 (E4BP4) as well, which is relevant to regulate the circadian rhythms and the viability of cells. More and more evidence has shown that NFIL3 is associated with different cardiovascular diseases. In recent years, it has been found that NFIL3 has significant functions in the progression of atherosclerosis (AS) via the regulation of inflammatory response, macrophage polarization, some immune cells and lipid metabolism. In this overview, we sum up the function of NFIL3 during the development of AS and offer meaningful views how to treat cardiovascular disease related to AS.


Subject(s)
Atherosclerosis , Interleukin-3 , Humans , Basic-Leucine Zipper Transcription Factors/metabolism
4.
Mol Reprod Dev ; 74(11): 1419-27, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17393421

ABSTRACT

Successful embryo implantation and pregnancy in mammals depends on the establishment of immune tolerance between the maternal immune system and fetal cells. Monoclonal nonspecific suppressor factor beta (MNSFbeta), a cytokine produced by suppressor T cells in various tissues, possesses an antigen-nonspecific immune-suppressive function, and may be involved in the regulation of the uterine immune response during embryo implantation. In this study, anti-MNSFbeta IgG administered directly into the uterine lumen, significantly inhibited mouse embryo implantation in a dose-dependent manner in vivo, and this effect was reversed by co-administration of recombinant MNSFbeta. The effects of anti-MNSFbeta IgG on the gene pattern profiles in mouse uterine tissues were examined by cDNA microarray and several changes were confirmed by real-time PCR. Anti-MNSFbeta IgG caused up-regulation (> or = 2-fold) of 71 known genes and 17 unknown genes, and decreased expression (> or = 2-fold) of 74 known genes and 43 unknown genes, including several genes previously associated with embryo implantation or fetal development. Most of the known genes are involved in immune regulation, cell cycle/proliferation, cell differentiation/apoptosis, and lipid/glucose metabolism. These results demonstrate that MNSFbeta plays critical roles during the early pregnancy via multiple pathways.


Subject(s)
Antibodies/pharmacology , Embryo Implantation/drug effects , Endometrium/drug effects , Immunoglobulin G/pharmacology , Suppressor Factors, Immunologic/antagonists & inhibitors , Animals , Antibodies/immunology , Antibody Formation/drug effects , Embryo Implantation/genetics , Endometrium/metabolism , Female , Gene Expression Profiling , Immunoglobulin G/immunology , Insecta/cytology , Lipopolysaccharides/immunology , Mice , Mice, Inbred ICR , Oligonucleotide Array Sequence Analysis , Pregnancy , Rabbits , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/genetics , Recombinant Proteins/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Suppressor Factors, Immunologic/genetics , Suppressor Factors, Immunologic/pharmacology
5.
Reproduction ; 128(4): 433-41, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15454638

ABSTRACT

The endometrium is hostile to embryo implantation except during the 'window of receptivity'. A change in endometrial gene expression is required for the development of receptivity. Calbindin-d9k (CaBP-d9k) and calbindin-d28k (CaBP-d28k) are proteins possessing EF-hand motifs which have high affinity for Ca2+ ions. Previously, it has been demonstrated that, in mouse endometrium, the expression of both calbindins is highly regulated during implantation and that both proteins play critical but functionally redundant roles at implantation. This study was the first to determine the expression of these two calbindins in the human and rhesus monkey endometrium. Initial RT-PCR analysis demonstrated that CaBP-d28k but not CaBP-d9k mRNA expression is detectable in the endometrium of both species. Western blot analysis confirmed the presence of immuno-reactive CaBP-d28k protein in the primate endometrium. Furthermore, the endometrial expression pattern of CaBP-d28k mRNA and protein was examined by Northern blot analysis and immunohistochemistry respectively in both species across the menstrual cycle and during early pregnancy. Semi-quantitative statistical analysis of the immunohistochemistry results revealed that, in the human, CaBP-d28k protein expression was maximal in luminal and glandular epithelium during the mid-secretory phase, coinciding with the time when the endometrium is receptive to embryo implantation. Expression in rhesus monkey showed a similar trend. These results suggest that, in the primate endometrium, only CaBP-d28k is expressed and that the specific regulation of this calbindin is potentially important for the establishment of uterine receptivity.


Subject(s)
Embryo Implantation/physiology , Endometrium/chemistry , S100 Calcium Binding Protein G/analysis , Animals , Blotting, Northern/methods , Blotting, Western/methods , Calbindin 1 , Calbindins , Cell Line , Female , Humans , Immunohistochemistry/methods , Macaca mulatta , Oligonucleotide Array Sequence Analysis , Pregnancy , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , S100 Calcium Binding Protein G/genetics , Tissue Distribution
6.
Proc Natl Acad Sci U S A ; 101(21): 8028-33, 2004 May 25.
Article in English | MEDLINE | ID: mdl-15138301

ABSTRACT

The endometrium is receptive to embryo implantation only for a short period in each reproductive cycle: development of receptivity requires alterations in endometrial gene expression. Calbindin (CaBP)-d9k and CaBP-d28k are related proteins containing EF hand motifs that have a high affinity for Ca2+. We previously demonstrated that endometrial expression of CaBP-d9k mRNA is highly regulated during implantation in the mouse. This project aimed to determine the temporal and spatial expression of both CaBP proteins during early pregnancy and to establish whether they are necessary for blastocyst implantation. CaBP-d28k protein, like CaBP-d9k, was up-regulated in the endometrial epithelium just before implantation but disappeared at implantation sites after attachment. By the judicious intrauterine injection of morpholino oligonucleotides (MO) against CaBP-d9k into WT and CaBP-d28k null mice just before implantation, we selectively eliminated one or both CaBPs from the uterine epithelium. Implantation was blocked only when both CaBP-d9k and CaBP-d28k were absent: treated WT mice and untreated CaBP-d28k null mice were fertile. Furthermore, the effect on implantation was highly dependent on the timing of injection of MO. This report examining the function of implantation-related genes in the uterus using MO demonstrates that this technique is a highly effective means to specifically target uterine proteins in vivo. This study provides evidence for an absolute requirement for CaBPs during the early phase of embryo implantation, and thus that regulation of Ca2+ availability in the uterine environment of the implanting embryo is critical for successful implantation.


Subject(s)
Embryo Implantation/physiology , Endometrium/metabolism , Oligonucleotides, Antisense/metabolism , S100 Calcium Binding Protein G/genetics , S100 Calcium Binding Protein G/metabolism , Animals , Calbindins , Corpus Luteum/metabolism , Female , Immunohistochemistry , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Fluorescence , Molecular Weight , Oligonucleotides, Antisense/genetics , Pregnancy , S100 Calcium Binding Protein G/analysis , S100 Calcium Binding Protein G/chemistry
7.
Mol Hum Reprod ; 9(5): 279-90, 2003 May.
Article in English | MEDLINE | ID: mdl-12728021

ABSTRACT

This paper characterizes a novel gene, previously identified as uniquely regulated at implantation in mouse uterus. We cloned its full mRNA sequence encoding a serine protease possessing an IGF-binding domain and named it pregnancy-related serine protease (PRSP). PRSP is structurally similar to mammalian HtrA1 (56% amino acid similarity). Northern analysis revealed that the expression of PRSP mRNA was low before pregnancy, but it was increased at implantation and markedly up-regulated post-implantation. In-situ hybridization localized low levels of mRNA expression to the epithelium and stroma during very early pregnancy, but high expression to the decidual cells on day 8.5, primarily at the mesometrial pole where the placenta was forming. By day 10.5, PRSP mRNA was detected in the placenta. We also cloned an alternatively spliced PRSP mRNA that is expressed at a very low level. We located PRSP gene on chromosome 5 and established its intron/exon structure, which unambiguously explains how the two mRNA variants are produced through alternative splicing. Based on PRSP protein domain structure and its unique expression during pregnancy, we propose that PRSP plays an important role in the formation/function of the placenta.


Subject(s)
Placentation/physiology , Serine Endopeptidases/metabolism , Uterus/enzymology , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Female , Mice , Molecular Sequence Data , Organ Specificity , Pregnancy , RNA, Messenger/metabolism , Serine Endopeptidases/genetics , Up-Regulation
8.
Biol Reprod ; 68(2): 439-47, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12533406

ABSTRACT

The present investigation was conducted to identify and characterize an mRNA that was found by RNA differential display to be uniquely regulated at the sites of embryo implantation in mouse uterus. This mRNA was upregulated at the sites of blastocyst attachment at implantation and was identified as proprotein convertase 6 (PC6). PC6 mRNA level was low in the nonpregnant and early pregnant uterus before embryo implantation commenced (before Day 4.5, vaginal plug = Day 0). During the initiation and progression of blastocyst attachment (around Day 4.5), the mRNA was dramatically upregulated only at the implantation sites. The increased transcription was maintained on Day 5.5; the mRNA level declined slightly on Day 6.5 and then fell sharply to reach the nonpregnant level around Days 8.5-10.5. Thus, the upregulation is transient and coincides with the period of embryo attachment and implantation; it is also very specific to implantation sites. In situ hybridization analysis localized the mRNA expression predominantly in the decidual cells immediately surrounding the implanting embryo at the antimesometrial pole. Additionally, multiple mRNA species resulting from alternative splicing were observed in the uterus, as previously reported in the intestine and brain, and further analysis of these transcripts identified a uterine-specific PC6 mRNA. These data lead us to suggest that PC6 plays an important role in the processes of stromal cell decidualization and embryo implantation.


Subject(s)
Aspartic Acid Endopeptidases/metabolism , Embryo Implantation , Pregnancy, Animal/metabolism , RNA, Messenger/metabolism , Uterus/metabolism , Animals , Aspartic Acid Endopeptidases/genetics , Base Sequence/genetics , Blotting, Northern , Estrus/metabolism , Female , In Situ Hybridization , Intestinal Mucosa/metabolism , Mice , Molecular Sequence Data , Polymerase Chain Reaction/methods , Pregnancy , Proprotein Convertases , Reverse Transcriptase Polymerase Chain Reaction , Tissue Distribution , Up-Regulation , Uterus/enzymology
9.
Biochem J ; 371(Pt 1): 39-48, 2003 Apr 01.
Article in English | MEDLINE | ID: mdl-12513693

ABSTRACT

In the present study, we identified an additional member of the human high-temperature requirement factor A (HtrA) protein family, called pregnancy-related serine protease or HtrA3, which was most highly expressed in the heart and placenta. We cloned the full-length sequences of two forms (long and short) of human HtrA3 mRNA, located the gene on chromosome 4p16.1, determined its genomic structure and revealed how the two mRNA variants are produced through alternative splicing. The alternative splicing was also verified by Northern blotting. Four distinct domains were found for the long form HtrA3 protein: (i) an insulin/insulin-like growth factor binding domain, (ii) a Kazal-type S protease-inhibitor domain, (iii) a trypsin protease domain and (iv) a PDZ domain. The short form is identical to the long form except it lacks the PDZ domain. Comparison of all members of human HtrA proteins, including their isoforms, suggests that both isoforms of HtrA3 represent active serine proteases, that they may have different substrate specificities and that HtrA3 may have similar functions to HtrA1. All three HtrA family members showed very different mRNA-expression patterns in 76 human tissues, indicating a specific function for each. Interestingly, both HtrA1 and HtrA3 are highly expressed in the placenta. Identification of the tissue-specific function of each HtrA family member is clearly of importance.


Subject(s)
Chromosomes, Human, Pair 4 , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolism , Alternative Splicing , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Female , Gene Expression Regulation , High-Temperature Requirement A Serine Peptidase 1 , High-Temperature Requirement A Serine Peptidase 2 , Humans , Male , Mice , Mitochondrial Proteins , Molecular Sequence Data , Organ Specificity , Placenta/physiology , Pregnancy , Protein Isoforms , Protein Structure, Tertiary , Serine Endopeptidases/chemistry , Structural Homology, Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...